Efficacy of induction chemoradiotherapy with carboplatin and docetaxel for non-small cell lung cancer in stage III

被引：0
|
作者：
Isobe, K. [1 ]
Hata, Y. [1 ]
Sugino, K. [1 ]
Sano, G. [1 ]
Sakamoto, S. [1 ]
Takai, Y. [1 ]
Sasamoto, S. [1 ]
Shibuya, K. [1 ]
Takagi, K. [1 ]
Homma, S. [1 ]
机构：
[1] Toho Univ, Omori Med Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.18510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18510
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Toxicity of Chemoradiotherapy with Carboplatin and Irinotecan Followed by Consolidation Docetaxel for Unresectable Stage III Non-small Cell Lung Cancer
    Bastos, Bruno R.
    Hatoum, Georges F.
    Walker, Gail R.
    Tolba, Khaled
    Takita, Christiane
    Gomez, Jorge
    Santos, Edgardo S.
    Lopes, Gilberto
    Raez, Luis E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (04) : 533 - 539
  • [2] Induction chemotherapy versus chemoradiotherapy for stage III non-small cell lung cancer
    Higgins, K. A.
    Clough, R.
    Marks, L.
    Kelsey, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S59 - S60
  • [3] Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer:: A phase I study
    Wirth, LJ
    Lucca, J
    Ostler, P
    Fidias, P
    Lynch, C
    Jänne, PA
    Herbst, RS
    Johnson, BE
    Sugarbaker, DJ
    Mathisen, DJ
    Lukanich, JM
    Choi, NC
    Berman, SM
    Skarin, AT
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (05) : 1698 - 1704
  • [4] Neoadjuvant Chemoradiotherapy for Stage iii Non-Small Cell Lung Cancer
    Sher, David J.
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
  • [5] Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for Stage III non-small cell lung cancer
    Choong, Nicholas W.
    Vokes, Everett E.
    Haraf, Daniel J.
    Tothy, Peter K.
    Ferguson, Mark K.
    Kasza, Kristen
    Rudin, Charles M.
    Hoffman, Philip C.
    Krauss, Stuart A.
    Szeto, Livia
    Mauer, Ann M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) : 59 - 67
  • [6] Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non-small cell lung cancer: Focus on docetaxel
    Gandara, DR
    Lara, PN
    Goldberg, Z
    Lau, DHM
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (03) : 26 - 32
  • [7] Clinical Outcome of Palliative Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-small Cell Lung Cancer
    Katsui, Kuniaki
    Ogata, Takeshi
    Watanabe, Kenta
    Yoshio, Kotaro
    Kuroda, Masahiro
    Hiraki, Takao
    Kiura, Katsuyuki
    Maeda, Yoshinobu
    Toyooka, Shinichi
    Kanazawa, Susumu
    [J]. ACTA MEDICA OKAYAMA, 2021, 75 (03) : 269 - 277
  • [8] Efficacy of Concurrent Carboplatin-Paclitaxel Chemoradiotherapy with 66 Gy for Elderly Patients with Stage III Non-Small Cell Lung Cancer
    Miura, S.
    Inoue, K.
    Hontsu, S.
    Tanaka, H.
    Miyauchi, M.
    Asakawa, I.
    Tamamoto, T.
    Hasegawa, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S859 - S860
  • [9] Induction paclitaxel/carboplatin in early stage non-small cell lung cancer
    Pisters, KMW
    Kris, MG
    Bunn, PA
    Johnson, DH
    Ruckdeschel, JC
    Crowley, JJ
    Ginsberg, RJ
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (04) : 41 - 44
  • [10] Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer
    Tan, EH
    Wee, J
    Ang, PT
    Fong, KW
    Leong, SS
    Khoo, KS
    Tan, T
    Lee, KS
    Eng, P
    Hsu, A
    Tan, YK
    Chua, EJ
    Ong, YY
    [J]. ACTA ONCOLOGICA, 1999, 38 (08) : 1005 - 1009
12345